Kissei Pharmaceutical Co Ltd
TSE:4547

Watchlist Manager
Kissei Pharmaceutical Co Ltd Logo
Kissei Pharmaceutical Co Ltd
TSE:4547
Watchlist
Price: 3 740 JPY 0.67% Market Closed
Market Cap: 165.3B JPY
Have any thoughts about
Kissei Pharmaceutical Co Ltd?
Write Note

Kissei Pharmaceutical Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kissei Pharmaceutical Co Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Kissei Pharmaceutical Co Ltd
TSE:4547
Cash & Cash Equivalents
ÂĄ22.8B
CAGR 3-Years
-2%
CAGR 5-Years
-6%
CAGR 10-Years
-3%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash & Cash Equivalents
ÂĄ804.3B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
3%
Daiichi Sankyo Co Ltd
TSE:4568
Cash & Cash Equivalents
ÂĄ805.3B
CAGR 3-Years
32%
CAGR 5-Years
25%
CAGR 10-Years
17%
Otsuka Holdings Co Ltd
TSE:4578
Cash & Cash Equivalents
ÂĄ485.9B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
2%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash & Cash Equivalents
ÂĄ462.9B
CAGR 3-Years
34%
CAGR 5-Years
21%
CAGR 10-Years
16%
Astellas Pharma Inc
TSE:4503
Cash & Cash Equivalents
ÂĄ302.9B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
-2%

See Also

What is Kissei Pharmaceutical Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
22.8B JPY

Based on the financial report for Jun 30, 2024, Kissei Pharmaceutical Co Ltd's Cash & Cash Equivalents amounts to 22.8B JPY.

What is Kissei Pharmaceutical Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-3%

Over the last year, the Cash & Cash Equivalents growth was -6%. The average annual Cash & Cash Equivalents growth rates for Kissei Pharmaceutical Co Ltd have been -2% over the past three years , -6% over the past five years , and -3% over the past ten years .

Back to Top